Share on StockTwits
 

Chelsea Therapeutics International (NASDAQ:CHTP) was the recipient of unusually large options trading on Tuesday. Traders purchased 8,498 put options on the company, American Banking News reports. This represents an increase of 130% compared to the average volume of 3,692 put options.

A number of research firms have recently commented on CHTP. Analysts at Roth Capital raised their price target on shares of Chelsea Therapeutics International to $7.00 in a research note on Friday, January 17th. Separately, analysts at Deutsche Bank raised their price target on shares of Chelsea Therapeutics International from $4.00 to $5.00 in a research note on Wednesday, January 15th. They now have a “hold” rating on the stock. Finally, analysts at Ladenburg Thalmann raised their price target on shares of Chelsea Therapeutics International to $7.00 in a research note on Wednesday, January 15th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $7.00.

Shares of Chelsea Therapeutics International (NASDAQ:CHTP) traded down 0.57% during mid-day trading on Tuesday, hitting $5.19. The stock had a trading volume of 9,456,665 shares. Chelsea Therapeutics International has a one year low of $0.76 and a one year high of $5.78. The stock has a 50-day moving average of $4.15 and a 200-day moving average of $3.37. The company’s market cap is $367.3 million.

Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.